The Global In-Vitro Diagnostics Quality Control Market was valued at US$ 900 Million in 2019. In-vitro diagnostics are assessments that can discover illnesses, disorders, or contagions. Some of the tests are used in the laboratory or other health professional locations and other tests are for patients to conduct at home. They comprise medical devices and equipment used to execute assessments on specimens so as to assist to discover the contagion, to detect a medical disorder, to avert illness, and to monitor medication treatments. The global IVD quality control market is mainly propelled by the increased number of certified clinical labs, growing demand for third-party quality controls, and escalating commonness of chronic and contagious illnesses. An increasing number of certified clinical labs worldwide and the presence of promising governing organizations are anticipated to be the main factors expanding the market growth. Diagnostic labs are observing fast advancement due to the huge predominance of disorders, such as diabetes, Cardiovascular Diseases (CVDs), and contagious illnesses. Many private, as well as public labs, are undergoing laboratory accreditation procedures to satisfy industry criteria, enhance their procedural volume, and lure more patients.
The North America led the global IVD quality controls market in 2019, and is projected to remain in leading position throughout the evaluation period, as a result of surge in demand for technically superior multi-analytical controls and strict directives for using controls. The APAC region is estimated to be the rapidly developing region over the assessment timeline as the region has a huge potential for this market because of the growing number of product manufacturing corporations. Besides, the Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine has been boosting the application of IVDs. Therefore, an increase in consciousness for initial and accurate diagnosis promotes the product demand and ultimately the IVD quality control market in the region. Also, the presence of key regulatory authorities in the region, such as the Ministry of Health, Labor and Welfare (MHLW), Pharmaceuticals and Medical Devices Evaluation Agency (PMDA), and Ministry of Agriculture and Fisheries and Food, will support the market growth.
In Vitro Diagnostics (IVD) Quality Control Market Share Analysis, by Geography (2021)
The report titled “In Vitro Diagnostics (IVD) Quality Control Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032” wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global In Vitro Diagnostics (IVD) Quality Control Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global In Vitro Diagnostics (IVD) Quality Control market is segmented depending on application, type, end-use, and geography. By application, the IVD quality control market is divided into Immunochemistry, Hematology, Clinical Chemistry, Molecular Diagnostics, Coagulation, Microbiology, and Others. The type segment is further divided into quality control, quality assurance services, data management. Based on end-use the market is segmented into hospitals, labs, home-care, and others. Based on geography, the global In Vitro Diagnostics (IVD) Quality Control market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, the United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Indonesia, Australia, South Korea, Taiwan, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on In Vitro Diagnostics quality control. Further, market share of prominent companies in the global In Vitro Diagnostics (IVD) Quality Control Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the In-vitro diagnostics companies. The global In Vitro Diagnostics (IVD) Quality Control Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the In-vitro diagnostics business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global In Vitro Diagnostics (IVD) Quality Control Market.
Major players active in the global In Vitro Diagnostics (IVD) Quality Control Market Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Sero AS, Siemens Healthcare GmbH, Bio-Techne, Qiagen N.V., Sysmex Corp., Abbott Laboratories, Inc., Becton, Quidel Corp., Dickinson, and Company (BD), bioMerieux, Inc., Alere, Inc., Hologic, Inc. (Gen-Probe), and Roche Diagnostics.
By Application:
- Immunochemistry
- Hematology
- Clinical Chemistry
- Molecular Diagnostics
- Coagulation
- Microbiology
- Others
By Application:
- Immunochemistry
- Hematology
- Clinical Chemistry
- Molecular Diagnostics
- Coagulation
- Microbiology
- Others
By Type:
- Quality control
- Quality assurance services
- Data management
By End Use:
- Hospitals
- Home healthcare
- Diagnostic Laboratories
- Others
By Geography :
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Belgium
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- Rest of Middle East & Africa
- South America
- Brazil
- Rest of South America
1. Introduction 1.1. Research Objectives 1.2. Report Assumptions 1.3. Research Methodology 1.4. Abbreviations 2. Preface 2.1. Market Definition 2.2. Report Scope and Market Segmentation 2.3. Research Highlights 3. Market Synopsis: Global In-Vitro Diagnostics Quality Control Market 4. Global In-Vitro Diagnostics Quality Control Market Qualitative Analysis 4.1. Ecosystem Analysis 4.1.1. Role of participants 4.1.2. Integration scenario 4.2. Trends 4.2.1. Market trends 4.2.2. Technology Trends 4.3. PESTEL Analysis (For 5 prominent countries) 4.4. Market Influencers 4.4.1. Driving Forces 4.4.2. Hindering Forces 4.4.3. Opportunities 4.5. Rules & Regulations 5. Global In-Vitro Diagnostics Quality Control Market Analysis and Forecast, by Application 5.1. Overview and definitions 5.2. Key segment analysis 5.3. Global In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Application, 2018 – 2030 5.3.1. Immunochemistry 5.3.2. Hematology 5.3.3. Clinical Chemistry 5.3.4. Molecular Diagnostics 5.3.5. Coagulation 5.3.6. Microbiology 5.3.7. Others 6. Global In-Vitro Diagnostics Quality Control Market Analysis and Forecast, by Type 6.1. Overview and definitions 6.2. Key segment analysis 6.3. Global In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Type, 2018 – 2030 6.3.1. Quality Control 6.3.2. Quality Assurance Services 6.3.3. Data Management 7. Global In-Vitro Diagnostics Quality Control Market Analysis and Forecast, by End Use 7.1. Overview and definitions 7.2. Key segment analysis 7.3. Global In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), End Use, 2018 – 2030 7.3.1. Hospitals 7.3.2. Home Healthcare 7.3.3. Laboratories 7.3.4. Others 8. Global In-Vitro Diagnostics Quality Control Market Analysis and Forecast, by Region 8.1. Overview and definitions 8.2. Key segment analysis 8.3. Global In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Region, 2018 – 2030 8.3.1. North America 8.3.2. Europe 8.3.3. Asia Pacific 8.3.4. Middle East & Africa 8.3.5. South America 9. North America In-Vitro Diagnostics Quality Control Market Analysis and Forecast 9.1. Overview and definitions 9.2. Key segment analysis 9.3. North America In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Application, 2018 – 2030 9.3.1. Immunochemistry 9.3.2. Hematology 9.3.3. Clinical Chemistry 9.3.4. Molecular Diagnostics 9.3.5. Coagulation 9.3.6. Microbiology 9.3.7. Others 9.4. North America In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Type, 2018 – 2030 9.4.1. Quality Control 9.4.2. Quality Assurance Services 9.4.3. Data Management 9.5. North America In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), End Use, 2018 – 2030 9.5.1. Hospitals 9.5.2. Home Healthcare 9.5.3. Laboratories 9.5.4. Others 9.6. North America In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), Country, 2018 – 2030 9.6.1. The U.S. 9.6.2. Canada 9.6.3. Rest of North America 10. Europe In-Vitro Diagnostics Quality Control Market Analysis and Forecast 10.1. Overview and definitions 10.2. Key segment analysis 10.3. Europe In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Application, 2018 – 2030 10.3.1. Immunochemistry 10.3.2. Hematology 10.3.3. Clinical Chemistry 10.3.4. Molecular Diagnostics 10.3.5. Coagulation 10.3.6. Microbiology 10.3.7. Others 10.4. Europe In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Type, 2018 – 2030 10.4.1. Quality Control 10.4.2. Quality Assurance Services 10.4.3. Data Management 10.5. Europe In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), End Use, 2018 – 2030 10.5.1. Hospitals 10.5.2. Home Healthcare 10.5.3. Laboratories 10.5.4. Others 10.6. Europe In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), Country, 2018 – 2030 10.6.1. Germany 10.6.2. United Kingdom 10.6.3. Belgium 10.6.4. Spain 10.6.5. Rest of Europe 11. Asia Pacific In-Vitro Diagnostics Quality Control Market Analysis and Forecast 11.1. Overview and definitions 11.2. Key segment analysis 11.3. Asia Pacific In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Application, 2018 – 2030 11.3.1. Immunochemistry 11.3.2. Hematology 11.3.3. Clinical Chemistry 11.3.4. Molecular Diagnostics 11.3.5. Coagulation 11.3.6. Microbiology 11.3.7. Others 11.4. Asia Pacific In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Type, 2018 – 2030 11.4.1. Quality Control 11.4.2. Quality Assurance Services 11.4.3. Data Management 11.5. Asia Pacific In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), End Use, 2018 – 2030 11.5.1. Hospitals 11.5.2. Home Healthcare 11.5.3. Laboratories 11.5.4. Others 11.6. Asia Pacific In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), Country, 2018 – 2030 11.6.1. Japan 11.6.2. India 11.6.3. China 11.6.4. Australia 11.6.5. Rest of Asia Pacific 12. Middle East & Africa In-Vitro Diagnostics Quality Control Market Analysis and Forecast 12.1. Overview and definitions 12.2. Key segment analysis 12.3. Middle East & Africa In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Application, 2018 – 2030 12.3.1. Immunochemistry 12.3.2. Hematology 12.3.3. Clinical Chemistry 12.3.4. Molecular Diagnostics 12.3.5. Coagulation 12.3.6. Microbiology 12.3.7. Others 12.4. Middle East & Africa In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Type, 2018 – 2030 12.4.1. Quality Control 12.4.2. Quality Assurance Services 12.4.3. Data Management 12.5. Middle East & Africa In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), End Use, 2018 – 2030 12.5.1. Hospitals 12.5.2. Home Healthcare 12.5.3. Laboratories 12.5.4. Others 12.6. Middle East & Africa In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), Country, 2018 – 2030 12.6.1. Saudi Arabia 12.6.2. UAE 12.6.3. Rest of Middle East 13. South America In-Vitro Diagnostics Quality Control Market Analysis and Forecast 13.1. Overview and definitions 13.2. Key segment analysis 13.3. South America In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Application, 2018 – 2030 13.3.1. Immunochemistry 13.3.2. Hematology 13.3.3. Clinical Chemistry 13.3.4. Molecular Diagnostics 13.3.5. Coagulation 13.3.6. Microbiology 13.3.7. Others 13.4. South America In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), by Type, 2018 – 2030 13.4.1. Quality Control 13.4.2. Quality Assurance Services 13.4.3. Data Management 13.5. South America In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), End Use, 2018 – 2030 13.5.1. Hospitals 13.5.2. Home Healthcare 13.5.3. Laboratories 13.5.4. Others 13.6. South America In-Vitro Diagnostics Quality Control Market Estimates (US$ Mn), Country, 2018 – 2030 13.6.1. Brazil 13.6.2. Rest of South America 14. Competition Analysis – In-Vitro Diagnostics Quality Control Market 14.1. Market Composition 14.2. Market Share Analysis (%), by Supplier (2019) 14.3. Company Profiles 14.3.1. Thermo Fisher Scientific, Inc. 14.3.1.1. Business overview 14.3.1.2. Management 14.3.1.3. Geographic presence 14.3.1.4. Product portfolio 14.3.1.5. Financial facts 14.3.1.6. Channel partners 14.3.1.7. Relevant news and strategic view 14.3.2. Bio-Rad Laboratories, Inc. 14.3.3. Sero AS 14.3.4. Siemens Healthineers AG 14.3.5. Bio-Techne, Qiagen N.V. 14.3.6. Sysmex Corp. 14.3.7. Abbott Laboratories, Inc. 14.3.8. Becton, Dickinson and Company (BD) 14.3.9. Quidel Corp. 14.3.10. bioMerieux, Inc. 14.3.11. Alere, Inc. 14.3.12. Hologic, Inc. 14.3.13. Roche Diagnostics 15. Conclusion & Recommendations
